March 03, 2015

Quanex Building Products Corporation Reports First Quarter 2015 Results and Affirms Full Year 2015 Guidance

HOUSTON, March 3, 2015 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX), a leading supplier of window and door components, today released results for the first quarter ended January 31, 2015.

"While we expected roughly flat sales growth in the first quarter because of a planned contraction in our vinyl business, all of our other product lines continued to grow faster than the industry," said Chairman, President and Chief Executive Officer Bill Griffiths. "This, together with the current trajectory of our operating performance, gives us sufficient confidence to reaffirm our full year EBITDA guidance," said Griffiths.

Financial highlights for the first quarter include:

  • Q1 2015 net sales increased 1.2% to $128 million vs. $126 million in Q1 2014
  • Q1 2015 loss from continuing operations of ($3.1) million vs. loss of ($1.2) million in Q1 2014
  • Q1 2015 diluted loss per share from continuing operations of ($0.09) vs. ($0.03) in Q1 2014
  • Q1 2015 EBITDA of $2.6 million vs. $7.7 million in Q1 2014
  • Cash balance of $63.9 million and no borrowings on $150 million revolving credit facility

At the company's annual shareholder meeting held at the Company's corporate offices in Houston, Texas on February 26, 2015, board members Joseph D. Rupp and Robert R. Buck were elected by Quanex shareholders to serve a new three-year term expiring in 2018. Quanex shareholders also ratified an advisory resolution approving the compensation of the Company's named executive officers and the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2015.

Additionally, the Board of Directors declared a quarterly cash dividend of $0.04 per share on the company's common stock, payable March 31, 2015, to shareholders of record on March 16, 2015.

On September 5, 2014, the Board of Directors authorized a $75 million share repurchase program. The program was completed in February 2015, resulting in the repurchase of 3,992,229 shares at an average cost of $18.79 (inclusive of commissions).

Additional information related to first quarter 2015 results, including a reconciliation of EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) to its most comparable GAAP measure, can be found in the supplemental schedules accompanying this press release.

Conference Call Information

Quanex will host its conference call today, March 3, 2015 at 11:00 a.m. (Eastern) to discuss its results and outlook. The call will be available via webcast at in the Investors section.

Forward-Looking Statements

Statements that use the words "estimated," "expect," "could," "should," "believe," "will," "might," or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, future operating results of Quanex, the future financial condition of Quanex, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company's industry, and the Company's future growth, including revenue and EBITDA guidance. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. Factors that could impact future results may include, without limitation, the effect of both domestic and global economic conditions, the impact of competitive products and pricing, the availability and cost of raw materials, and customer demand. For a more complete discussion of factors that may affect the Company's future performance, please refer to the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2014, under the sections entitled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors," in our other documents filed with the Securities and Exchange Commission from time to time. Any forward-looking statements in this press release are made as of the date hereof, and Quanex Building Products Corporation undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

For additional information, please visit

(In thousands, except per share data)
  Three Months Ended January 31,
  2015 2014
Net sales  $ 127,893  $ 126,379
Cost of sales  105,804  96,189
Selling, general and administrative  19,496  22,503
Depreciation and amortization  8,208  8,544
Asset impairment charges  --   5
Operating loss  (5,615)  (862)
Interest expense  (141)  (141)
Other, net  (151)  96
Loss before income taxes  (5,907)  (907)
Income tax benefit (expense)  2,813  (304)
Loss from continuing operations  (3,094)  (1,211)
Income (loss) from discontinued operations, net of taxes  23  (2,689)
Net loss  $ (3,071)  $ (3,900)
Earnings (loss) per common share:    
From continuing operations  $ (0.09)  $ (0.03)
From discontinued operations  $ --   $ (0.08)
Diluted earnings (loss) per common share:    
From continuing operations  $ (0.09)  $ (0.03)
From discontinued operations  $ --   $ (0.08)
Weighted average common shares outstanding:    
Basic  35,079  37,003
Diluted  35,079  37,003
Cash dividends per share  $ 0.04  $ 0.04
(In thousands)
  January 31, 2015 October 31, 2014
Current assets:    
Cash and cash equivalents  $ 63,924  $ 120,384
Accounts receivable, net  39,334  55,193
Inventories, net   59,831  57,358
Deferred income taxes  24,662  21,442
Prepaid and other current assets  5,715  6,052
Total current assets  193,466  260,429
Property, plant and equipment, net  110,033  109,487
Deferred income taxes  7,295  1,545
Goodwill   68,802  70,546
Intangible assets, net  67,889  70,150
Other assets  5,524  4,956
Total assets  $ 453,009  $ 517,113
Current liabilities:    
Accounts payable  $ 31,016  $ 41,488
Accrued liabilities  22,920  32,482
Income taxes payable  --   107
Current maturities of long-term debt  190  199
Total current liabilities  54,126  74,276
Long-term debt  568  586
Deferred pension and postretirement benefits  5,309  4,818
Liability for uncertain tax positions  548  4,626
Other liabilities  11,152  11,887
Total liabilities  71,703  96,193
Stockholders' equity:    
Common stock  376  376
Additional paid-in-capital  249,497  249,600
Retained earnings  207,760  202,319
Accumulated other comprehensive loss  (8,528)  (5,708)
Treasury stock at cost  (67,799)  (25,667)
Total stockholders' equity  381,306  420,920
Total liabilities and stockholders' equity  $ 453,009  $ 517,113
(In thousands)
  Three Months Ended January 31,
  2015 2014
Operating activities:    
Net loss  $ (3,071)  $ (3,900)
Adjustments to reconcile net income (loss) to cash provided by operating activities:    
Depreciation and amortization  8,208  10,294
Stock-based compensation  1,264  1,090
Deferred income tax benefit  (3,239)  (1,885)
Excess tax benefit from share-based compensation  (60)  (1)
Asset impairment charges  --  510
Other, net  (478)  728
Changes in assets and liabilities, net of effects from acquisitions and dispositions:    
Decrease in accounts receivable  15,323  26,654
Increase in inventory  (2,920)  (15,998)
Increase in other current assets  (12)  (594)
Decrease in accounts payable  (10,298)  (10,894)
Decrease in accrued liabilities  (10,934)  (15,027)
Decrease (increase) in income taxes payable  (58)  26
Increase in deferred pension and postretirement benefits  520  915
Increase (decrease) in other long-term liabilities  13  (1,087)
Other, net  (5)  (2,315)
Cash used for operating activities  (5,747)  (11,484)
Investing activities:    
Acquisitions, net of cash acquired  --  (5,161)
Capital expenditures  (7,321)  (6,748)
Proceeds from property insurance claim  513  400
Proceeds from disposition of capital assets  --  303
Cash used in investing activities  (6,808)  (11,206)
Financing activities:    
Repayments of other long-term debt  (23)  (26)
Common stock dividends paid  (1,448)  (1,490)
Issuance of common stock  --  331
Excess tax benefit from share-based compensation  60  1
Purchase of treasury stock  (42,748)  --
Cash used in financing activities  (44,159)  (1,184)
Effect of exchange rate changes on cash and cash equivalents  254  (55)
Decrease in cash and cash equivalents  (56,460)  (23,929)
Cash and cash equivalents at beginning of period  120,384  49,736
Cash and cash equivalents at end of period  $ 63,924  $ 25,807
NOTE: The cash flow statement presentation includes the sources and uses of cash for the discontinued operations as operating, investing and financing cash flows, as applicable, combined with such cash flows for continuing operations, as permitted by U.S. GAAP.
(In thousands)
EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) is a non-GAAP financial measure that Quanex management uses to measure its operational performance and assist with financial decision-making. EBITDA is a key metric used by management in determining the value of annual incentive awards for its employees. We believe this non-GAAP measure (included under market conditions outlined in our forward-looking guidance) provides a consistent basis for comparison between periods, and will assist investors in understanding our financial performance when comparing our results to other investment opportunities. EBITDA may not be the same as that used by other companies. The company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with GAAP.
  Three Months Ended January 31,
  2015 2014
  Quanex Quanex
Net loss  $ (3,071)  $ (3,900)
(Income) loss from discontinued operations, net of taxes  (23)  2,689
Income tax (benefit) expense  (2,813)  304
Other, net  151  (96)
Interest expense  141  141
Operating loss  (5,615)  (862)
Depreciation and amortization  8,208  8,544
EBITDA  $ 2,593  $ 7,682
Financial Statistics as of January 31, 2015    
Book value per common share:   $11.22
Total debt to capitalization:    0.2%
Return on invested capital:    7.3%
Actual number of common shares outstanding:    33,976,102
(In millions, except per share data)
  Q1 2015   Q1 2014  
Pre-Tax Presentation $MM   $MM  
Operating Loss from Continuing Operations As Reported  $ (5.9)    $ (0.9)  
Benefit (Reduction) to Operating Income (Loss):        
IG Warranty Reserve Benefit  --     (2.8)  
Transaction Related Expenses  --     0.4  
Discontinued ERP Expenses*  --     0.3  
Operating Loss from Continuing Operations As Adjusted  $ (5.9)    $ (3.0)  
  Q1 2015 Q1 2015 Q1 2014 Q1 2014
After-Tax Presentation $MM EPS $MM EPS
Loss from Continuing Operations As Reported  $ (3.1)  $ (0.09)  $ (1.2)  $ (0.03)
Benefit (Reduction) to EPS:        
IG Warranty Reserve Benefit  --   --   (2.1)  (0.06)
Transaction Related Expenses  --   --   0.2  0.01
Discontinued ERP Expenses  --   --   0.2  0.01
Diluted Loss from Continuing Operations As Adjusted *  $ (3.1)  $ (0.09)  $ (2.9)  $ (0.07)
* Q1 2014 includes $258K of accelerated depreciation related to the SAP Implementation 
CONTACT: Financial Contact:
         Marty Ketelaar

         Media Contact:
         Valerie Calvert

Quanex Building Products Corporation Logo

Quanex Building Products Corporation